Curcumin for Neuroprotection: Taking a Second Look at Results

In an 18-month randomized, placebo-controlled trial, Small et  al. explored the effects of 180 mg of curcumin (Theracurmin) on verbal memory, visual memory, attention, and mood in elderly subjects without dementia.1 They also examined FDDNP brain PET scan binding in predefined regions of interest. They found that curcumin was superior to placebo on (only) o ne measure of verbal memory and on the attentional task, and that curcumin was associated with lower FDDNP binding than placebo in only the hypothalamus and not in any of seven other brain areas studied.

Source: The American Journal of Geriatric Psychiatry - March 30, 2018 Category: Geriatrics Authors: Migita Michael Dcruz, Spoorthy Sai Mamidipalli, Abha Thakurdesai, Chittaranjan Andrade Source Type: research